OPRX vs. SOHU, OOMA, NRC, IBEX, EGHT, MPLN, PMTS, ZH, SHAP, and RGP
Should you be buying OptimizeRx stock or one of its competitors? The main competitors of OptimizeRx include Sohu.com (SOHU), Ooma (OOMA), National Research (NRC), IBEX (IBEX), 8X8 (EGHT), MultiPlan (MPLN), CPI Card Group (PMTS), Zhihu (ZH), Spree Acquisition Corp. 1 (SHAP), and Resources Connection (RGP). These companies are all part of the "business services" industry.
OptimizeRx vs.
OptimizeRx (NASDAQ:OPRX) and Sohu.com (NASDAQ:SOHU) are both small-cap computer and technology companies, but which is the better investment? We will compare the two businesses based on the strength of their community ranking, media sentiment, earnings, profitability, risk, analyst recommendations, dividends, valuation and institutional ownership.
Sohu.com has a net margin of -15.14% compared to OptimizeRx's net margin of -27.41%. OptimizeRx's return on equity of -4.92% beat Sohu.com's return on equity.
76.5% of OptimizeRx shares are held by institutional investors. Comparatively, 33.0% of Sohu.com shares are held by institutional investors. 6.1% of OptimizeRx shares are held by insiders. Comparatively, 21.1% of Sohu.com shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Sohu.com received 57 more outperform votes than OptimizeRx when rated by MarketBeat users. However, 63.79% of users gave OptimizeRx an outperform vote while only 46.80% of users gave Sohu.com an outperform vote.
OptimizeRx has higher earnings, but lower revenue than Sohu.com. Sohu.com is trading at a lower price-to-earnings ratio than OptimizeRx, indicating that it is currently the more affordable of the two stocks.
OptimizeRx has a beta of 1.38, meaning that its share price is 38% more volatile than the S&P 500. Comparatively, Sohu.com has a beta of 1.13, meaning that its share price is 13% more volatile than the S&P 500.
In the previous week, OptimizeRx had 2 more articles in the media than Sohu.com. MarketBeat recorded 3 mentions for OptimizeRx and 1 mentions for Sohu.com. OptimizeRx's average media sentiment score of 0.85 beat Sohu.com's score of 0.10 indicating that OptimizeRx is being referred to more favorably in the media.
OptimizeRx presently has a consensus price target of $9.06, indicating a potential upside of 60.11%. Given OptimizeRx's stronger consensus rating and higher probable upside, equities research analysts plainly believe OptimizeRx is more favorable than Sohu.com.
Summary
OptimizeRx beats Sohu.com on 14 of the 18 factors compared between the two stocks.
Get OptimizeRx News Delivered to You Automatically
Sign up to receive the latest news and ratings for OPRX and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
OptimizeRx Competitors List
Related Companies and Tools
This page (NASDAQ:OPRX) was last updated on 2/11/2025 by MarketBeat.com Staff